RE: Investor 2018 london22 Apr 2018 11:06
I can see news on big pharma interest very soon. Why say it otherwise. The bottom line is the drug is safer than the market leader and more efficacious, with all the negativity surrounding this phase 3 it's a miracle benylista was granted approval but wtfdik